{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:19:01Z","timestamp":1793042341504,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["2023\/IN-TW\/08"],"award-info":[{"award-number":["2023\/IN-TW\/08"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["112-2923-M-400 -001-MY3"],"award-info":[{"award-number":["112-2923-M-400 -001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","award":["09\/0559(12946)\/2022-EMR-I"],"award-info":[{"award-number":["09\/0559(12946)\/2022-EMR-I"]}],"id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioorg.2024.108019","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T01:00:27Z","timestamp":1733274027000},"page":"108019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design"],"prefix":"10.1016","volume":"154","author":[{"given":"Himanshu","family":"Tahiliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunkumar","family":"Dhayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Pang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohane Selvaraj","family":"Coumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.108019_b0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0165-1218(91)90128-9","article-title":"Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment","volume":"259","author":"Feron","year":"1991","journal-title":"Mutation Res.\/Gene. Toxicol."},{"key":"10.1016\/j.bioorg.2024.108019_b0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10408440591002183","article-title":"Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health","volume":"35","author":"O\u2019Brien","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.bioorg.2024.108019_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","article-title":"Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis","volume":"51","author":"Ahmed Laskar","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bioorg.2024.108019_b0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2017.04.004","article-title":"Biogenic aldehydes as therapeutic targets for cardiovascular disease","volume":"33","author":"Nelson","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.108019_b0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/tx5001046","article-title":"Molecular mechanisms of aldehyde toxicity: a chemical perspective","volume":"27","author":"Lopachin","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2024.108019_b0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.4.6.697","article-title":"Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily","volume":"4","author":"Marchitti","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2024.108019_b0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-7364-2-2-138","article-title":"Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family","volume":"2","author":"Vasiliou","year":"2005","journal-title":"Hum. Genom."},{"key":"10.1016\/j.bioorg.2024.108019_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112940","article-title":"Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors","volume":"209","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","article-title":"Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer","volume":"7","author":"Feng","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/rda.12756","article-title":"Expression of retinoic acid-metabolizing enzymes, ALDH1A1, ALDH1A2, ALDH1A3, CYP26A1, CYP26B1 and CYP26C1 in canine testis during post-natal development","volume":"51","author":"Kasimanickam","year":"2016","journal-title":"Rep. Domest. Anim."},{"key":"10.1016\/j.bioorg.2024.108019_b0055","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.fertnstert.2013.12.053","article-title":"Levels of the retinoic acid synthesizing enzyme ALDH1A2 are lower in testicular tissue from men with infertility","volume":"101","author":"Amory","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bioorg.2024.108019_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11101553","article-title":"ALDH1A2 is a candidate tumor suppressor gene in ovarian cancer","volume":"11","author":"Choi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.108019_b0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ijc.30091","article-title":"ALDH1A3, a metabolic target for cancer diagnosis and therapy","volume":"139","author":"Duan","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.108019_b0070","first-page":"356","article-title":"A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth","volume":"13","author":"Gelardi","year":"2021","journal-title":"Invas. Stem. Vitro. Cancers"},{"key":"10.1016\/j.bioorg.2024.108019_b0075","doi-asserted-by":"crossref","first-page":"20679","DOI":"10.1073\/pnas.1901075116","article-title":"Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer","volume":"116","author":"Mameishvili","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2024.108019_b0080","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.18632\/oncotarget.23506","article-title":"Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2024.108019_b0085","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3389\/fgene.2019.01013","article-title":"The role of single-nucleotide polymorphisms in the function of candidate tumor suppressor ALDH1L1","volume":"10","author":"Krupenko","year":"2019","journal-title":"Front Genet."},{"key":"10.1016\/j.bioorg.2024.108019_b0090","series-title":"Alcohol and Cancer","first-page":"127","article-title":"ALDH1L1 and ALDH1L2 folate regulatory enzymes in cancer","author":"Krupenko","year":"2018"},{"key":"10.1016\/j.bioorg.2024.108019_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40246-020-00291-3","article-title":"Aldh1l2 knockout mouse metabolomics links the loss of the mitochondrial folate enzyme to deregulation of a lipid metabolism observed in rare human disorder","volume":"14","author":"Krupenko","year":"2020","journal-title":"Hum Genom."},{"key":"10.1016\/j.bioorg.2024.108019_b0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14728222.2019.1690454","article-title":"Aldehyde dehydrogenase-2 as a therapeutic target","volume":"23","author":"Kimura","year":"2019","journal-title":"Exp. Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2024.108019_b0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.chemrestox.8b00256","article-title":"Role of aldehyde dehydrogenases in physiopathological processes","volume":"32","author":"Rodr\u00edguez-Zavala","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2024.108019_b0110","doi-asserted-by":"crossref","first-page":"1211141","DOI":"10.3389\/fnagi.2023.1211141","article-title":"Implication of the cooking oil-peroxidation product \u201chydroxynonenal\u201d for Alzheimer\u2019s disease","volume":"15","author":"Yamashima","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2024.108019_b0115","article-title":"Aldehyde Dehydrogenases","author":"Vasiliou","year":"2018","journal-title":"Third Edit."},{"key":"10.1016\/j.bioorg.2024.108019_b0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2020.01.183","article-title":"Aldehyde dehydrogenase 3A1 confers oxidative stress resistance accompanied by altered DNA damage response in human corneal epithelial cells","volume":"150","author":"Voulgaridou","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0125","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.7150\/jca.58250","article-title":"ALDH3A1 driving tumor metastasis is mediated by p53\/BAG1 in lung adenocarcinoma","volume":"12","author":"Fan","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioorg.2024.108019_b0130","first-page":"1","article-title":"Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.108019_b0135","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm401508p","article-title":"Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells","volume":"57","author":"Parajuli","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/TACG.S193969","article-title":"Sjogren-larsson syndrome: Mechanisms and management","volume":"13","author":"Bindu","year":"2020","journal-title":"Appl. Clin. Gene."},{"key":"10.1016\/j.bioorg.2024.108019_b0145","first-page":"1","article-title":"Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis","volume":"20","author":"Yin","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2024.108019_b0150","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.freeradbiomed.2010.08.004","article-title":"Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress","volume":"49","author":"Marchitti","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12192-022-01306-9","article-title":"ALDH3B1 protects interfollicular epidermal cells against lipid peroxidation via the NRF2 pathway","volume":"27","author":"Wu","year":"2022","journal-title":"Cell Stress Chaperon."},{"key":"10.1016\/j.bioorg.2024.108019_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04451-8","article-title":"Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2024.108019_b0165","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/pro.4131","article-title":"Structural basis for the stereospecific inhibition of the dual proline\/hydroxyproline catabolic enzyme ALDH4A1 by trans-4-hydroxy-L-proline","volume":"30","author":"Bogner","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2024.108019_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpsychires.2020.02.001","article-title":"ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism","volume":"123","author":"Nagaoka","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41586-020-2993-2","article-title":"ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies","volume":"589","author":"Lorenzo","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.108019_b0180","doi-asserted-by":"crossref","unstructured":"X. Tian, Y. Han, L. Yu B. Luo, Z. Hu, X. Li et al., Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer. 18 (2017) 245\u2013251. doi: 101080\/1538404720171295175.","DOI":"10.1080\/15384047.2017.1295175"},{"key":"10.1016\/j.bioorg.2024.108019_b0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-016-1659-5","article-title":"A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma","volume":"133","author":"El-Habr","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bioorg.2024.108019_b0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cbf.3584","article-title":"ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma","volume":"39","author":"Deng","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bioorg.2024.108019_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-98","article-title":"Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria","volume":"8","author":"Marcadier","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bioorg.2024.108019_b0200","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.18632\/aging.204270","article-title":"The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer","volume":"14","author":"Cai","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.bioorg.2024.108019_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146757","article-title":"ALDH6A1 weakens the progression of colon cancer via modulating the RAS\/RAF\/MEK\/ERK pathway in cancer cell lines","volume":"842","author":"Li","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2024.108019_b0210","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1021\/acs.jproteome.9b00846","article-title":"Identification of ALDH6A1 as a potential molecular signature in hepatocellular carcinoma via quantitative profiling of the mitochondrial proteome","volume":"19","author":"Shin","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02268-1","article-title":"ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma","volume":"18","author":"Lu","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0220","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2147\/IJGM.S343727","article-title":"Downregulation of ALDH6A1 is a new marker of muscle insulin resistance in type 2 diabetes mellitus","volume":"15","author":"Liu","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bioorg.2024.108019_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-022-00702-3","article-title":"ALDH7A1 rs12514417 polymorphism may increase ischemic stroke risk in alcohol-exposed individuals","volume":"19","author":"Lin","year":"2022","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.bioorg.2024.108019_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112782","article-title":"EPS8 supports pancreatic cancer growth by inhibiting BMI1 mediated proteasomal degradation of ALDH7A1","volume":"407","author":"Tan","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0240","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.18632\/aging.204099","article-title":"The impact of ALDH7A1 variants in oral cancer development and prognosis","volume":"14","author":"Lu","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.bioorg.2024.108019_b0245","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1074\/jbc.RA118.003320","article-title":"Reassignment of the human aldehyde dehydrogenase ALDH8A1 (ALDH12) to the kynurenine pathway in tryptophan catabolism","volume":"293","author":"Davis","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0250","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.2147\/OTT.S203342","article-title":"Five hub genes can be the potential DNA methylation biomarkers for cholangiocarcinoma using bioinformatics analysis","volume":"12","author":"Chen","year":"2019","journal-title":"OncoTargets Therapy."},{"key":"10.1016\/j.bioorg.2024.108019_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108477","article-title":"Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1","volume":"691","author":"Wyatt","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2024.108019_b0260","doi-asserted-by":"crossref","first-page":"e0122589","DOI":"10.1371\/journal.pone.0122589","article-title":"Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer","volume":"10","author":"Henrion","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108019_b0265","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cbi.2012.12.018","article-title":"ALDH16A1 is a novel non-catalytic enzyme that may be involved in the etiology of gout via protein-protein interactions with HPRT1","volume":"202","author":"Vasiliou","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2024.108019_b0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2017.02.013","article-title":"Transcriptomic analysis and plasma metabolomics in Aldh16a1-null mice reveals a potential role of ALDH16A1 in renal function","volume":"276","author":"Charkoftaki","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2024.108019_b0275","doi-asserted-by":"crossref","unstructured":"Z. Ding, R.E. Ericksen, Q.Y. Lee, W. Han, Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis, 2021.","DOI":"10.1007\/s00726-021-02961-5"},{"key":"10.1016\/j.bioorg.2024.108019_b0280","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1016\/S0021-9258(19)40899-5","article-title":"Human liver aldehyde dehydrogenase. Esterase activity","volume":"250","author":"Sidhu","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0285","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2024.108019_b0290","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1073\/pnas.122225199","article-title":"Identification of the enzymatic mechanism of nitroglycerin bioactivation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2024.108019_b0295","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","article-title":"Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells","author":"Vasiliou","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2024.108019_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3904645","article-title":"Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.bioorg.2024.108019_b0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nsb0497-317","article-title":"The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold","volume":"4","author":"Liu","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bioorg.2024.108019_b0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1110\/ps.8.1.137","article-title":"Relationships within the aldehyde dehydrogenase extended family","volume":"8","author":"Perozich","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2024.108019_b0315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jmb.2018.11.030","article-title":"Crystal structure of aldehyde dehydrogenase 16 reveals trans-hierarchical structural similarity and a new dimer","volume":"431","author":"Liu","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.108019_b0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1073\/pnas.1011223108","article-title":"Structural shifts of aldehyde dehydrogenase enzymes were instrumental for the early evolution of retinoid-dependent axial patterning in metazoans","volume":"108","author":"Sobreira","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2024.108019_b0325","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.3390\/cancers15174419","article-title":"Human aldehyde dehydrogenases: a superfamily of similar yet different proteins highly related to cancer","volume":"15","author":"Xanthis","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.108019_b0330","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1002\/mco2.195","article-title":"Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets","volume":"4","author":"Xia","year":"2023","journal-title":"MedComm."},{"key":"10.1016\/j.bioorg.2024.108019_b0335","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tips.2019.08.002","article-title":"Aldehyde dehydrogenase inhibitors for cancer therapeutics","volume":"40","author":"Dinavahi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.108019_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123033","article-title":"ALDH and cancer stem cells: pathways, challenges, and future directions in targeted therapy","volume":"356","author":"Lavudi","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2024.108019_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.795762","article-title":"Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance","volume":"9","author":"Zanoni","year":"2022","journal-title":"Front Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0350","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1349-7006.2009.01151.x","article-title":"Stem cell marker aldehyde dehydrogenase 1\u2010positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression","volume":"100","author":"Morimoto","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2024.108019_b0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-016-3738-7","article-title":"Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype","volume":"156","author":"Kida","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.bioorg.2024.108019_b0360","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","article-title":"Aldehyde dehydrogenase 1 Is a marker for normal and malignant human colonic Stem Cells (SC) and tracks SC overpopulation during colon tumorigenesis","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21873\/anticanres.13924","article-title":"High Expression of c-Met, PKC\u03bb and ALDH1A3 predicts a poor prognosis in late-stage breast cancer","volume":"40","author":"Motomura","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2024.108019_b0370","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1073\/pnas.1221478110","article-title":"Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3","volume":"110","author":"Mao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2024.108019_b0375","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41419-018-1232-3","article-title":"ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2024.108019_b0380","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41388-020-1184-9","article-title":"Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer","volume":"39","author":"Rebollido-Rios","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2024.108019_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045190","article-title":"Functional specialization in proline biosynthesis of melanoma","volume":"7","author":"De Ingeniis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108019_b0390","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8694","article-title":"Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN -amplified neuroblastoma growth","volume":"12","author":"Guo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0395","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/jm501900s","article-title":"Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors","volume":"58","author":"Morgan","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0400","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1021\/acs.jmedchem.5b00577","article-title":"Discovery of NCT-501, a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1)","volume":"58","author":"Yang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0405","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1021\/acs.jmedchem.8b00930","article-title":"Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy","volume":"61","author":"Huddle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0410","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","article-title":"Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0415","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/0929867043455747","article-title":"Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes","volume":"11","author":"Villarroya","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0420","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/en.2011-2104","article-title":"Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism","volume":"153","author":"Kiefer","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2024.108019_b0425","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nm1587","article-title":"Retinaldehyde represses adipogenesis and diet-induced obesity","volume":"13","author":"Ziouzenkova","year":"2007","journal-title":"Nat Med."},{"key":"10.1016\/j.bioorg.2024.108019_b0430","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/antiox12071466","article-title":"Aldehyde dehydrogenase and aldo-keto reductase enzymes: basic concepts and emerging roles in diabetic retinopathy","volume":"12","author":"Karan","year":"2023","journal-title":"Antioxidants."},{"key":"10.1016\/j.bioorg.2024.108019_b0435","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/cbin.12188","article-title":"Aldehyde dehydrogenase 1 family: a potential molecule target for diseases","volume":"48","author":"Duan","year":"2024","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bioorg.2024.108019_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103971","article-title":"Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity","volume":"101","author":"Ma","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0445","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/acs.jmedchem.6b01825","article-title":"Inhibition of the aldehyde dehydrogenase 1\/2 family by psoralen and coumarin derivatives","volume":"60","author":"Buchman","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbi.2014.12.038","article-title":"Discovery of a series of aromatic lactones as ALDH1\/2-directed inhibitors","volume":"234","author":"Buchman","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2024.108019_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116352","article-title":"Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity","volume":"46","author":"Ma","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0460","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/jm401377v","article-title":"Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones","volume":"57","author":"Kimble-Hill","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0465","doi-asserted-by":"crossref","first-page":"43486","DOI":"10.1074\/jbc.M111.293597","article-title":"Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases","volume":"286","author":"Khanna","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111962","article-title":"Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents","volume":"187","author":"Dinavahi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108019_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127958","article-title":"Development of new disulfiram analogues as ALDH1a1-selective inhibitors","volume":"40","author":"Omran","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108019_b0480","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/molecules27020480","article-title":"Novel disulfiram derivatives as ALDH1a1-selective inhibitors","volume":"27","author":"Omran","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.108019_b0485","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.2174\/1381612825666190816233755","article-title":"An updated review of disulfiram: molecular targets and strategies for cancer treatment","volume":"25","author":"Yang","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2024.108019_b0490","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/cbic.201300625","article-title":"Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity","volume":"15","author":"Parajuli","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2024.108019_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110910","article-title":"Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes","volume":"391","author":"Takahashi","year":"2024","journal-title":"Chem. Biol. Interact."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:31:15Z","timestamp":1778661075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824009246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":99,"alternative-id":["S0045206824009246"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108019","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108019"}}